Literature DB >> 12778462

The role of interleukin-12 in human infectious diseases: only a faint signature.

Claire Fieschi1, Jean-Laurent Casanova.   

Abstract

IL-12 is the signature IFN-gamma-inducing cytokine and, as such, is thought to be crucial for protective immunity against intracellular microorganisms. This concept is supported by results from experimental infections of knockout mice lacking IL-12 or the IL-12 receptor. The description of human patients with inherited IL-12 or IL-12-receptor deficiency challenges this view. Indeed, in natural conditions of infection and immunity - the hallmark of the human model - IL-12 was found to be redundant in defense against intracellular microorganisms other than Mycobacteria and Salmonella. More surprisingly, IL-12 was recently found to be redundant even in defense against primary intection by Mycobacteria and Salmonella in many patients, and against secondary infection by Mycobacteria but not Salmonella in most patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12778462     DOI: 10.1002/eji.200324038

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Complete deficiency of the IL-12 receptor beta1 chain: three unrelated Turkish children with unusual clinical features.

Authors:  Gonul Tanir; Figen Dogu; Nilden Tuygun; Aydan Ikinciogullari; Caner Aytekin; Cumhur Aydemir; Mutlu Yuksek; Esin Cengiz Boduroglu; Ludovic de Beaucoudrey; Claire Fieschi; Jacqueline Feinberg; Jean-Laurent Casanova; Emel Babacan
Journal:  Eur J Pediatr       Date:  2006-02-24       Impact factor: 3.183

2.  A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Xinghong Yang; Sarah Golden; Catharine M Bosio; Kathryn Crist; Todd Becker; Massimo Maddaloni; David W Pascual
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

3.  Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections.

Authors:  Ozden Sanal; Tuba Turul; Tijtske De Boer; Esther Van de Vosse; Işik Yalcin; Ilhan Tezcan; Cağman Sun; L Memis; Tom H M Ottenhoff; Fugen Ersoy
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

Review 4.  Chemical mutagenesis: a new strategy against the global threat of infectious diseases.

Authors:  Etienne Richer; Salman T Qureshi; Silvia M Vidal; Danielle Malo
Journal:  Mamm Genome       Date:  2008-06-17       Impact factor: 2.957

5.  Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab.

Authors:  Jacqueline M Benson; Clifford W Sachs; George Treacy; Honghui Zhou; Charles E Pendley; Carrie M Brodmerkel; Gopi Shankar; Mary A Mascelli
Journal:  Nat Biotechnol       Date:  2011-07       Impact factor: 54.908

Review 6.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

7.  An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Richard Bowen; Xinghong Yang; Kathryn Crist; Sarah Golden; Massimo Maddaloni; David W Pascual
Journal:  Vaccine       Date:  2008-10-26       Impact factor: 3.641

8.  Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.

Authors:  Nora Koutruba; Jason Emer; Mark Lebwohl
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

9.  Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.

Authors:  Daniela Bosisio; Marisa Vulcano; Annalisa Del Prete; Marina Sironi; Valentina Salvi; Laura Salogni; Elena Riboldi; Flavio Leoni; Charles A Dinarello; Giampiero Girolomoni; Silvano Sozzani
Journal:  J Leukoc Biol       Date:  2008-09-09       Impact factor: 4.962

10.  High dose interleukin-12 exacerbates Bordetella pertussis infection and is associated with suppression of cell-mediated immunity in a murine aerosol challenge model.

Authors:  C R D Carter; B M Dagg; K M Whitmore; J R Keeble; C Asokanathan; D Xing; K B Walker
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.